BioCARE: Biomarkers in Cancer Medicine improving Health Care, Education and Innovation
121 – 130 of 3081
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
PO-0978 Accurate positioning with decreased treatment time using surface guided tomotherapy : ESTRO 38, 26-30 April 2019, Milan, Italy
- Contribution to journal › Published meeting abstract
-
Mark
A Population-Based Comparison of the AJCC 7th and AJCC 8th Editions for Patients Diagnosed with Stage III Cutaneous Malignant Melanoma in Sweden
- Contribution to journal › Article
-
Mark
Preclinical efficacy of hK2 targeted [177Lu]hu11B6 for prostate cancer theranostics
- Contribution to journal › Article
-
Mark
Development and Implementation of Survivorship Tools to Enable Medical Follow-Up After Childhood Cancer Treatment in Southern Sweden
- Contribution to journal › Article
-
Mark
Beta-sheet-specific interactions with heat shock proteins define a mechanism of delayed tumor cell death in response to HAMLET
- Contribution to journal › Article
-
Mark
Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants : An ENIGMA resource to support clinical variant classification
- Contribution to journal › Article
-
Mark
Cancer therapy and risk of congenital malformations in children fathered by men treated for testicular germ-cell cancer: A nationwide register study
- Contribution to journal › Article
-
Mark
Assessment of Subfascial Muscle/Water and Fat Accumulation in Lymphedema Patients Using Magnetic Resonance Imaging
- Contribution to journal › Article
-
Mark
Incidence of Nocturia in Men with Lower Urinary Tract Symptoms Associated with Benign Prostatic Enlargement and Outcomes After Medical Treatment : Results from the Evolution European Association of Urology Research Foundation Prospective Multinational Registry
(2019) In European Urology Focus
- Contribution to journal › Article
-
Mark
Association of Immune Marker Changes with Progression of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma
(2019) In JAMA Oncology
- Contribution to journal › Article
